Holdings

Orbimed Advisors LLC

As of Sep 30, 2026, Orbimed Advisors LLC reported 105 positions worth US$5.15B. Largest: Edgewise Therapeutics, Inc., ADARx Pharmaceuticals, Inc. and Enliven Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Edgewise Therapeutics, Inc.15.5MUS$630Mno changeSep 30, 2026
ADARx Pharmaceuticals, Inc.24.2MUS$483MnewSep 30, 2026
Enliven Therapeutics, Inc.6.78MUS$311Mno changeSep 30, 2026
Eli Lilly and Company258KUS$298Mno changeSep 30, 2026
Braveheart Bio, Inc.12.2MUS$246MnewSep 30, 2026
Sinovac Biotech, Ltd.2.72MUS$196Mno changeSep 30, 2026
MBX Biosciences, Inc.3.07MUS$180M−354KSep 30, 2026
Merck & Company, Inc.946KUS$137M+283KSep 30, 2026
Guardant Health, Inc.584KUS$104M+400Sep 30, 2026
ArriVent BioPharma, Inc.3.03MUS$91.7Mno changeSep 30, 2026